Home/Filings/4/0001213900-24-094632
4//SEC Filing

Almenoff June Sherie 4

Accession 0001213900-24-094632

CIK 0001388320other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 5:12 PM ET

Size

6.0 KB

Accession

0001213900-24-094632

Insider Transaction Report

Form 4
Period: 2024-11-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-11-01+50,00050,000 total
    Exercise: $1.71Exp: 2034-11-01Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Represents a grant of stock options granted in connection with the Reporting Person's appointment as a director of the Issuer's Board of Directors. The exercise price represents the closing stock price of the Issuer's common stock, par value $0.001 per share, on November 1, 2024, the date of the grant.
  • [F2]The options shall vest as follows: (i) 28% of the options shall vest on the 12-month anniversary of the date of grant, and (ii) 2% of the options shall vest each month from the date of grant, until fully vested.

Documents

1 file

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1
  • filerCIK 0001492647

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:12 PM ET
Size
6.0 KB